Method for rapidly separating four bifidobacteria

Through comparative genomic analysis and designing methods of shared and unique primers, combined with PCR and nucleic acid electrophoresis, the difficulty of isolating and distinguishing Bifidobacterium from complex samples was solved, and the rapid, accurate and efficient distinction effect was achieved, reducing costs .

CN118932094APending Publication Date: 2024-11-12NORTHEAST AGRICULTURAL UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411316954.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-20
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The prior art is difficult to effectively isolate and distinguish Bifidobacterium bifidobacterium brevis, Bifidobacterium long subspecies and Bifidobacterium long subspecies from complex samples, and there are problems of difficulty in identifying and high cost.

Method used

Through comparative genomic analysis of the glycoside hydrolase family genes of Bifidobacterium, design common and unique primers, and combine colony PCR and nucleic acid electrophoresis technology, a method to quickly distinguish four Bifidobacterium was developed, using common and unique primers for PCR amplification and the separation results were verified by gel electrophoresis.

Benefits of technology

The rapid, accurate and efficient distinction between the four Bifidobacterium species in complex samples is achieved, reducing the cost of isolation and identification, and improving the speed and specificity of detection.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118932094A_ABST
    Figure CN118932094A_ABST
Patent Text Reader

Abstract

The invention relates to a method for rapidly separating four bifidobacteria. The invention provides a group of PCR (Polymerase Chain Reaction) primers for separating and identifying four bifidobacteria including bifidobacterium bifidum, bifidobacterium breve, bifidobacterium longum subsp. Longum and bifidobacterium longum subsp. Infantis, and application of the PCR primers. The method comprises the following steps: 1) comparing glycoside hydrolase (GH) family genes of four bifidobacteria through comparative genomics, and searching common and respective specific glycoside hydrolase family genes; 2) designing common and specific primers of the four bifidobacteria according to a comparison result; (3) carrying out PCR (Polymerase Chain Reaction) amplification by using a bacterial colony or DNA (Deoxyribonucleic Acid) of a target bacterium and applying the designed primer, and carrying out nucleic acid electrophoresis verification on an amplification product; and 4) proving that the bifidobacterium is one of the four bifidobacteria when double positive bands appear at a target position. The bifidobacterium of the corresponding species is separated from a complex sample through the primer provided by the invention, and the purposes of accuracy, simplicity, convenience, high efficiency and low cost can be achieved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of microbial detection, and mainly relates to PCR primers for separating and identifying four types of bifidobacteria, namely, bifidobacterium bifidum, bifidobacterium breve, bifidobacterium longum subspecies longum and bifidobacterium longum subspecies infantis. Background Art

[0002] Bifidobacterium is a type of Gram-positive, anaerobic bacteria belonging to the Bifidobacteriaceae family of the Actinomycetes phylum. Bifidobacterium has a wide range of beneficial effects on humans. It can relieve adverse intestinal symptoms and play a key role in enhancing host immunity, regulating the balance of intestinal flora, and preventing colitis. Bifidobacterium has significant carbohydrate metabolism capabilities, and its related metabolic genes account for approximately 14.62% of the total genome. Genomic studies have shown that bifidobacteria carry a variety of genes related to carbohydrate metabolism, including glycoside hydrolases, carbohydrate binding modules, and glycosyltransferases. Although bifidobacteria show general commonalities in carbohydrate metabolism, there are also significant differences between different species or subspecies.

[0003] Bifidobacterium mainly exists in the intestines of warm-blooded animals, and its isolation usually relies on the processing of fecal samples. In order to effectively separate the four bifidobacteria commonly found in the infant intestine, namely Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium longum subsp. longum and Bifidobacterium longum subsp. infantis, from infant feces. This study adopted a comparative genomics strategy, combined with the advantages of bifidobacteria in carbohydrate metabolism genes, and conducted a comparative genomics analysis of the common and unique glycoside hydrolase family genes of these four bifidobacteria. Common and unique primers were designed for the common and unique glycoside hydrolase family genes, and a method for rapid differentiation of the four bifidobacteria was developed using colony PCR and nucleic acid electrophoresis technology. Summary of the invention

[0004] The present invention finds that it is difficult to separate different species or subspecies of bifidobacteria from complex samples. Through comparative genomics, it is found that different species or subspecies have commonality and specificity in glycoside hydrolase (GH). Therefore, a method, detection primers, kit and related applications for quickly distinguishing four types of bifidobacteria from complex samples are designed based on their common and unique glycoside hydrolase family genes.

[0005] In order to realize the above method, the present invention focuses on the comparison of glycoside hydrolase (GH) family genes for the strong carbohydrate metabolism ability of bifidobacteria, selects glycoside hydrolase family genes that are contained in or unique to four bifidobacteria as common or unique molecular markers of four bifidobacteria, and selects highly conserved sequences common to four bifidobacteria to design common and unique primers for four bifidobacteria according to the comparison and alignment results. The common primers for four bifidobacteria designed according to the alignment results of the GH13-11 family genes common to four bifidobacteria are allF and allR, and the PCR sequence amplified using the primers is about 1046bp (B.bifidumATCC29521).

[0006] The specific GH30_5 family genes of Bifidobacterium longum subsp. longum were aligned, and the specific primers of Bifidobacterium longum subsp. longum were designed as loF and loR. The PCR sequence amplified using the primers was about 641 bp (B. longum subsp. longum JCM1217).

[0007] The specific GH13-44 family genes of Bifidobacterium breve were aligned, and the specific primers brF and brR of Bifidobacterium breve were designed. The PCR sequence amplified using the primers was about 522 bp (B. breve UCC2003).

[0008] The specific GH30_5 family genes of Bifidum bifidum were aligned, and the specific primers for Bifidum bifidum were designed as biF and biR. The PCR sequence amplified using these primers was about 843 bp (B. bifidum ATCC29521).

[0009] Bifidobacterium longum subsp. infantis does not have a specific glycoside hydrolase family, but it has two GH29 families, one of which is specific. The specific primers for Bifidobacterium longum subsp. infantis are designed based on the alignment of the gene, which are inF and inR. The PCR sequence amplified using the primers is approximately 739 bp (B. longum subsp. infantis AT CC15697).

[0010] Colony PCR is performed on the colonies on the coated plate in the complex sample according to the designed primers, and the PCR amplification products are verified by gel electrophoresis. The bifidobacterium isolated is the specific double positive result at the specific position.

[0011] The above primers allF and allR correspond to SEQ NO.1 and SEQ NO.2 respectively, and the target sequence corresponding to them is SEQ NO.3.

[0012] The above primers loF and loR correspond to SEQ NO.4 and SEQ NO.5 respectively, and the target sequence corresponding to them is SEQ NO.6.

[0013] The above primers brF and brR correspond to SEQ NO.7 and SEQ NO.8 respectively, and the target sequence corresponding to them is SEQ NO.9.

[0014] The above primers biF and biR correspond to SEQ NO.10 and SEQ NO.11 respectively, and the target sequence corresponding to them is SEQ NO.12.

[0015] The above primers inF and inR correspond to SEQ NO. 13 and SEQ NO. 14 respectively, and the target sequence corresponding to them is SEQ NO. 15.

[0016] As a preferred technical solution, the solid culture medium mentioned above is MRS culture medium added with 0.005% mupirocin lithium salt and 0.05% cysteine ​​hydrochloride.

[0017] Preferably, 0.9% agarose gel is used for nucleic acid electrophoresis.

[0018] As a preferred technical solution, the PCR reaction system is 20 μL as follows:

[0019] 1 μL of bacterial colony or bacterial DNA template; 10 μL of 2xPCR MixⅡ; 0.5 μL of upstream and downstream primers each; ddH2O to make up to 20 μL.

[0020] Preferably, the 2xPCR Mix II includes PCR buffer, Taq enzyme and dNTPs.

[0021] As a preferred technical solution, the reaction conditions of PCR are as follows:

[0022] Pre-denaturation at 95°C for 5 min; denaturation at 95°C for 20 s, annealing at 60°C for 30 s, extension at 72°C for 1.5 min, 35 cycles; supplementary extension at 72°C for 2 min.

[0023] The PCR method for separating and identifying four types of bifidobacteria established using the identification primers provided by the present invention specifically comprises the following steps:

[0024] (1) Dilute and spread the sample to be tested, purify it, and select a single colony.

[0025] (2) Optionally, a single colony is cultured and its DNA is extracted.

[0026] (3) The single colony obtained in the above step (1) or the DNA obtained in the optional step (2) is subjected to PCR amplification according to the primers shown above to obtain a PCR amplification product.

[0027] (4) subjecting the amplified product to gel electrophoresis, and separating four types of bifidobacteria, namely, Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium longum subsp. longum, and Bifidobacterium longum subsp. infantis, according to the bands appearing in the gel electrophoresis; the electrophoresis result is one of the following:

[0028] a: There are only DNA bands with molecular weights of 1046 bp and 641 bp, which are determined to be Bifidobacterium longum subspecies longum;

[0029] b: There are only DNA bands with molecular weights of 1046 bp and 522 bp, which is determined to be Bifidobacterium breve;

[0030] c: There are only DNA bands with molecular weights of 1046 bp and 843 bp, which is determined to be Bifidobacterium bifidum;

[0031] d: There are only DNA bands with molecular weights of 1046 bp and 739 bp, which are determined to be Bifidobacterium longum subsp. infantis;

[0032] e: No band or only one band means no result or a false positive result, which means it is not one of the four types of Bifidobacterium mentioned above.

[0033] Preferably, the above step (2) is an optional scheme. In order to be simpler and more efficient, directly using the colony for PCR can also achieve the effect of differentiation. The DNA extraction method is carried out according to the bacterial DNA extraction kit produced by Tiangen Biochemical Technology (Beijing) Co., Ltd.

[0034] Preferably, when the primers are used for PCR in the above step (3), all five pairs of primers are added to the reaction system, and the five pairs of primers have good specificity and will not interfere with each other.

[0035] The present invention aims to propose a set of specific primers for separating four types of bifidobacteria, namely, Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium longum subsp. longum and Bifidobacterium longum subsp. infantis. The experiments and detailed descriptions made are not necessary or limiting conditions for applying for a patent.

[0036] The present invention has the beneficial technical features of:

[0037] The present invention is based on comparative genomics, by comparing all four bifidobacteria with complete genome sequences and clear species or subspecies information in the NCBI database, including 27 strains of B.breve, 24 strains of B.longum subsp.longum, 18 strains of B.bifidum, and 18 strains of B.longum subsp.infantis, by comparing the stronger glycoside hydrolase family genes of bifidobacteria, conservative sequences are selected for primer design. This group of primers contains 5 pairs in total, which are divided into 1 pair of common primers and 1 pair of specific primers of each of the four bifidobacteria. Compared with the prior art, the primers provided by the present invention have not been reported, and this method not only reduces the cost of separation and identification, but also has the characteristics and advantages of high efficiency and speed. BRIEF DESCRIPTION OF THE DRAWINGS

[0038] Figure 1 Primers were designed to extract fragments for four bifidobacteria: Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium longum subsp. longum and Bifidobacterium longum subsp. infantis.

[0039] Figure 2 The electrophoresis diagrams are the validation electrophoresis diagrams of the common and unique primers for each strain.

[0040] Figure 3 The electrophoresis diagrams show the verification of double primers common to each strain and the unique primers for each strain, as well as the verification of 5 mixed primers.

[0041] Figure 4 Electrophoresis of colony PCR using five primers.

[0042] Figure 5 Construction of Bifidobacterium phylogenetic tree based on 16S rDNA sequences. DETAILED DESCRIPTION

[0043] The specific embodiments of the present invention are described in detail below with reference to the accompanying drawings.

[0044] Example 1

[0045] Comparative genomics analysis of common and unique glycoside hydrolase (GH) family genes in four bifidobacteria

[0046] The complete genome information of 87 strains of Bifidobacterium with clear species or subspecies information was downloaded from the GenBank database in NCBI, including 27 strains of B.breve, 24 strains of B.longum subsp.longum, 18 strains of B.bifidu m, and 18 strains of B.longum subsp.infantis. The hummr software was used to download the corresponding GH family HMM package for local batch annotation of glycoside hydrolase families for the genome sequences of each species and subspecies. Detailed strain information is shown in Table 1. The annotation results were analyzed and compared according to the species and subspecies of Bifidobacterium to find the genes of the common and unique glycoside hydrolase families. The common glycoside hydrolase family GH13-11 was found as the sequence for the common primer design. GH13-44 is a unique glycoside hydrolase family gene of Bifidobacterium breve. GH30_5 is unique to Bifidobacterium longum subsp. longum; GH84 only exists in all Bifidobacterium bifidum. Bifidobacterium longum subsp. infantis has two GH29 family genes, and one of them was selected.

[0047] The conserved sequences of the glycoside hydrolase family genes of the four bifidobacteria were selected for primer design. The selected GH13-11 family gene corresponds to SEQNO.16; the selected GH30_5 family gene corresponds to SEQNO.17; the selected GH13-44 family gene corresponds to SEQNO.18; the selected GH84 family gene corresponds to SEQNO.19; and the selected GH29 family gene corresponds to SEQNO.20. The partial results of the comparison are shown in Figure 1 .

[0048] It should be understood that due to space limitations, Figure 1 It is an excerpt of the selected glycoside hydrolase family gene alignment based on the primers designed according to the conserved sequence. The complete sequence GH13-11 family gene corresponds to SEQNO.16; the selected GH30_5 family gene corresponds to SEQNO.17; the selected GH13-44 family gene corresponds to SEQNO.18; the selected GH84 family gene corresponds to SEQNO.19; and the selected GH29 family gene corresponds to SEQNO.20.

[0049] Table 1 All strains subjected to gene comparison

[0050]

[0051]

[0052] Example 2

[0053] Primers were designed based on the conserved sequences of the selected sequences. The five pairs of primers designed are shown in Table 2 Table 2 Common primers and unique primer design sequences of four types of Bifidobacteria

[0054]

[0055]

[0056] The primers allF and allR designed in Table 2 above correspond to SEQ NO. 1 and SEQ NO. 2 respectively. The sequence corresponding to the PCR amplification product is 1046 bp, and the corresponding target sequence is SEQ NO. 3.

[0057] The primers loF and loR designed in Table 2 above correspond to SEQ NO. 4 and SEQ NO. 5, respectively. The sequence corresponding to the PCR amplification product is 641 bp, and the corresponding target sequence is SEQ NO. 6.

[0058] The primers brF and brR designed in Table 2 above correspond to SEQ NO. 7 and SEQ NO. 8 respectively. The sequence corresponding to the PCR amplification product is 522 bp, and the corresponding target sequence is SEQ NO. 9.

[0059] The primers biF and biR designed in Table 2 above correspond to SEQ NO. 10 and SEQ NO. 11 respectively. The sequence corresponding to the PCR amplification product is 843 bp, and the corresponding target sequence is SEQ NO. 12.

[0060] The primers inF and inR designed in Table 2 correspond to SEQ NO. 13 and SEQ NO. 14 respectively. The sequence corresponding to the PCR amplification product is 739 bp, and the corresponding target sequence is SEQ NO. 15.

[0061] It should be understood that the primers provided by the present invention are used to distinguish bacterial species and are not actually limited to a specific strain. The design of the primers is based on the conserved sequences of the glycoside hydrolase family genes obtained by gene comparison. The amplification products obtained vary depending on the strain. The target sequence displayed above only shows the sequence of a specific bacterial strain.

[0062] The specific target sequence strains correspond to the following:

[0063] SEQ NO.3 corresponds to the target sequence of B. bifidum ATCC29522 (NCBI Reference Sequence: NZ_AP012323.1);

[0064] SEQ NO.6 corresponds to the target sequence of B. longum subsp. longum JCM1217 (NCBI Reference Sequence: NC_015067.1);

[0065] SEQ NO.9 corresponds to the target sequence of B. breve UCC2003 (NCBI Reference Sequence: NC_020517.1);

[0066] SEQ NO.12 corresponds to the target sequence of B. bifidum ATCC29522 (NCBI Reference Sequence: NZ_AP012323.1);

[0067] SEQ NO.15 corresponds to the target sequence of B. longum subsp. infantis ATCC15697 (NCBI Reference Sequence: NC_011593.1).

[0068] Example 3

[0069] Processing of samples to be tested

[0070] Collect feces from volunteers who have not taken antibiotics and probiotics within 3 months and have no gastrointestinal diseases. Store the collected feces in a sterile collection tube and temporarily store it in an ice bag foam box. Complete the sample processing within 2 hours. In a clean workbench, pick a small amount of fecal sample, dilute it in a gradient with sterile PBS (pH 7.4) buffer solution, and spread each gradient of fecal sample dilution on MRS solid culture medium with 0.005% mupirocin lithium salt and 0.05% cysteine ​​hydrochloride. Culture it anaerobically at 37°C for 48-72 hours, and pick milky white or white colonies with smooth appearance and moist edges.

[0071] The important habitat of bifidobacteria is the intestine of warm-blooded animals. The present invention focuses on the four common bifidobacteria in the intestine of infants, and describes it using infant feces as an example. In fact, the method of the present invention is applicable to the separation of bifidobacteria from various samples containing one or more of the four bifidobacteria.

[0072] It should be understood that the method of the present invention is not limited to a certain sample. The method of the present invention can be applied to the separation of bifidobacteria in various samples. The infant feces sample mentioned above is only a specific implementation case mentioned, and does not limit the application of the present invention to the separation of bifidobacteria in other samples.

[0073] Example 4

[0074] Verify the specificity of consensus and unique primers

[0075] Use the colony or DNA of the tested Bifidobacterium and use the common and unique substances for PCR amplification, and detect the amplified products by nucleic acid gel electrophoresis. The results are shown in Figure 2 ,3 .

[0076] The tested strains are listed in Table 3.

[0077] Table 3 Test strain information

[0078]

[0079] First, one strain of Bifidobacterium bifidum, Bifidobacterium longum subsp. infantis, Bifidobacterium longum subsp. longum and Bifidobacterium breve were selected from the test strains (corresponding to Figure 1 Lanes 1, 2, 3, and 4) and selected Bifidobacterium animalis subsp. lactis Bb12 ( Figure 1 Lane 5) was used as a control, and its DNA was used as a template to verify the common primers (allF, allR) designed in this study. Figure 2 The nucleic acid gel electrophoresis diagram showed that all strains had bright and clear bands at a specific position (about 1000 bp), while strain Bb12 had no bands, indicating that the common primers designed in this study had good specificity.

[0080] According to the above method, the specific primers (biF, biR; brF, brR; inF, inR; loF, loR) designed in this study for Bifidobacterium bifidum, Bifidobacterium longum subsp. infantis, Bifidobacterium longum subsp. longum and Bifidobacterium breve were verified respectively. Figure 2 ). In the figure, B.bifidum Figure 2 The band in lane 6 is about 800 bp; B. longum subsp. Infantis Figure 2 The band in lane 7 appeared at about 700 bp; B. longum subsp. longum Figure 2 The band in lane 8 appears at about 600 bp; B. breve Figure 2 The band in lane 9 appeared at about 500 bp, and the position of the band was consistent with expectations, indicating that the specific primers designed in this experiment also had good specificity. In order to effectively distinguish Bifidobacterium bifidum, Bifidobacterium longum subsp. infantis, Bifidobacterium longum subsp. longum and Bifidobacterium breve, the four strains were verified by double primers according to the above method ( Figure 3 Lanes 1-4), that is, the "double positive result" with double bands appearing at specific positions, proves the effectiveness of the primers. Figure 3 The band results of lanes 1-4 verified by double primers were consistent with the band results verified by the above single primers.

[0081] In order to prevent the accidental results of the test and eliminate the mutual interference between primers, all nine test strains were used to verify the five mixed primers ( Figure 3Lanes 6-14), the results showed that all tested strains had clear and bright double bands at specific positions, proving that the designed primers had good specificity and the primers would not interfere with each other.

[0082] The common and unique primers designed in this study were verified by strains with clear species information, indicating that this method is effective. By using 5 mixed primers to amplify a specific template by PCR, the amplified product was verified by nucleic acid electrophoresis. As long as double positive bands appeared at a specific position, it could be determined as a suspected strain of the corresponding species.

[0083] The information of the strains involved in the primer verification is shown in Table 4

[0084] Table 4: Information of strains involved in primer validation

[0085]

[0086] The above DNA extraction is carried out according to the instructions of the DNA extraction kit. The present invention uses a bacterial genomic DNA extraction kit produced by Tiangen Biochemical Technology (Beijing) Co., Ltd. to extract bacterial DNA. In fact, this is an optional step. In order to be faster and more efficient, PCR can be performed using bacterial colonies. The kit used in the present invention does not limit the implementation of the present invention, and any brand of bacterial DNA extraction kit or other method for extracting bacterial DNA is applicable.

[0087] The above 20 μL PCR reaction system is:

[0088] 1 μL DNA template; 10 μL 2xPCR MixⅡ; 0.5 μL each of upstream and downstream primers; 20 μL ddH2O.

[0089] The above PCR amplification conditions are:

[0090] Pre-denaturation at 95°C for 5 min; denaturation at 95°C for 20 s, annealing at 60°C for 30 s, extension at 72°C for 1.5 min, 35 cycles; supplementary extension at 72°C for 2 min.

[0091] The above agarose gel electrophoresis conditions are:

[0092] Use 0.9% agarose gel with nucleic acid dye for nucleic acid electrophoresis, set the electrophoresis instrument voltage to 150V, the time to 25 minutes, and observe the distribution of bands in the agarose gel in an imager.

[0093] The above-mentioned method for determining a "double positive result" should include the following steps:

[0094] (1) Dilute and spread the sample to be tested, purify it, and select a single colony.

[0095] (2) Optionally, a single colony is cultured and its DNA is extracted.

[0096] (3) The single colony obtained in the above step (1) or the DNA obtained in the optional step (2) is subjected to PCR amplification according to the primers shown above to obtain a PCR amplification product.

[0097] (4) subjecting the amplified product to gel electrophoresis, and separating four types of bifidobacteria, namely, Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium longum subsp. longum, and Bifidobacterium longum subsp. infantis, according to the bands appearing in the gel electrophoresis; the electrophoresis result is one of the following:

[0098] a: There are only DNA bands with molecular weights of 1046 bp and 641 bp, which are determined to be Bifidobacterium longum subspecies longum;

[0099] b: There are only DNA bands with molecular weights of 1046 bp and 522 bp, which is determined to be Bifidobacterium breve;

[0100] c: There are only DNA bands with molecular weights of 1046 bp and 843 bp, which is determined to be Bifidobacterium bifidum;

[0101] d: There are only DNA bands with molecular weights of 1046 bp and 739 bp, which are determined to be Bifidobacterium longum subsp. infantis;

[0102] e: No band or only one band means no result or a false positive result, which means it is not one of the four types of Bifidobacterium mentioned above.

[0103] Example 5

[0104] The primers were used to isolate four species of Bifidobacterium from fecal samples.

[0105] The sample was processed according to the requirements of the above Example 3 and the corresponding colonies were picked for PCR amplification using 5 pairs of primers provided by the present invention. The amplification method and gel electrophoresis conditions were carried out according to the requirements of Example 4. From the electrophoresis diagram, it can be seen that: double positive bands appeared at about 1000 bp and 800 bp in lanes 11, 13, 14 and 31, which were determined to be suspected strains of Bifidobacterium bifidum; in addition, Figure 4 Lanes 4, 5, 10, 25, 28 and 29 in the present double positive bands at about 1000 bp and 600 bp, according to the fragment lengths obtained by PCR amplification using the primers designed in this study, it is inferred that they are suspected to be Bifidobacterium longum subsp. longum; according to this method, lane 12 with double positive bands at about 1000 bp and 700 bp and lanes 9 and 22 with double positive bands at about 1000 bp and 500 bp are suspected to be Bifidobacterium longum subsp. infantis and Bifidobacterium breve, respectively.

[0106] Example 6

[0107] 16S rDNA sequencing of the suspected Bifidobacterium

[0108] Each of the above-mentioned isolates was amplified and cultured in MRS liquid medium with 0.05% cysteine ​​hydrochloride, and the DNA of each isolate was extracted using a kit according to the method in Example 4, and PCR amplification was performed using the primers 27F (5'-AGAGTTTGATCCTGGCTCAG-3') and 1492R (5'-GGTTACCTTGTTACGAC TT-3') with its DNA as a template, and the amplified product was sent to Jilin Kumei Biotechnology Co., Ltd. for sequencing. The sequencing results were compared with the known sequences in the NCBI database, and the neighbor-joining method was used to construct a phylogenetic tree to determine the bacterial species. The phylogenetic tree constructed based on the measured strains is as follows: Figure 5 , wherein the bacteria in lanes 4, 5, 10, 25, 28 and 29 were identified as Bifidobacterium longum subsp. longum; the bacteria in lanes 11, 13, 14 and 31 were identified as Bifidobacterium bifidum; the bacteria in lane 12 were identified as Bifidobacterium longum subsp. infantis; and the bacteria in lanes 9 and 22 were identified as Bifidobacterium breve. The primer sequence 27F mentioned above specifically corresponds to SEQ NO. 21; and the primer 1492R corresponds to SEQ NO. 22.

[0109] Specific primers are verified by PCR of colonies or DNA. Figure 2 , 3 As shown, the primers provided by the present invention have good specificity and do not interfere with each other. The "double positive band" method proposed by the present invention further enhances the innovation of the present invention. For a specific strain, as long as a double positive band appears at a specific position, it can be determined as a bifidobacterium of the corresponding species. Specifically, if there are and only DNA bands with molecular weights of about 1046bp and 641bp, it is determined to be a long subspecies of Bifidobacterium longum; if there are and only DNA bands with molecular weights of about 1046bp and 522bp, it is determined to be a short Bifidobacterium; if there are and only DNA bands with molecular weights of about 1046bp and 843bp, it is determined to be a bifidobacterium bifidum; if there are and only DNA bands with molecular weights of about 1046bp and 739bp, it is determined to be a long subspecies of Bifidobacterium infantis. By separating the corresponding species of bifidobacteria from complex samples through the primers provided by the present invention, the purpose of accuracy, simplicity, efficiency and low cost can be achieved.

[0110] The above embodiments are only for explaining the description of the present invention, and are not intended to limit the application of the present invention. Any changes, substitutions, modifications, etc. made by those skilled in the art without departing from the spirit of the present invention should fall within the protection scope of the present invention.

Claims

1. A set of multiplex PCR primers for four types of bifidobacteria designed based on the strong glycoside hydrolase family genes of bifidobacteria, characterized in that : The specific GH30_5 family genes of Bifidobacterium longum subsp. longum were aligned, and the specific primers of Bifidobacterium longum subsp. longum were designed as loF and loR. The PCR sequence amplified using these primers was about 641 bp ( B. longum subsp. longum JCM1217) The specific GH13-44 family genes of Bifidobacterium breve were aligned, and the specific primers brF and brR of Bifidobacterium breve were designed. The PCR sequence amplified using these primers was about 521 bp ( B. breve UCC2003) The specific GH30_5 family genes of Bifidobacterium bifidum were aligned, and the specific primers for Bifidobacterium bifidum were designed as biF and biR. The PCR sequence amplified using these primers was about 843 bp ( B. bifidum ATCC29521) Bifidobacterium longum infantis subsp. infantis does not have a specific glycoside hydrolase family, but it has two GH29 families, one of which is specific. The specific primers for Bifidobacterium longum infantis subsp. infantis were designed based on the alignment of the gene, inF and inR. The PCR sequence amplified using the primers was approximately 739 bp ( B. longum subsp. infantile ATCC15697) According to the designed primers, colony PCR was performed on the colonies on the coated plate in the complex sample, and the PCR amplification products were verified by gel electrophoresis. The presence of a specific double positive result at a specific position was the isolated bifidobacterium. The above primers allF and allR correspond to SEQ NO.1 and SEQ NO.2 respectively, and the target sequence corresponds to SEQ NO.3 The above primers loF and loR correspond to SEQ NO.4 and SEQ NO.5 respectively, and the target sequence corresponding to SEQ NO.6 The above primers brF and brR correspond to SEQ NO.7 and SEQ NO.8 respectively, and the target sequence corresponding to SEQ NO.9 The above primers biF and biR correspond to SEQ NO.10 and SEQ NO.11 respectively, and the target sequence corresponding to SEQ NO.12 The above primers inF and inR correspond to SEQ NO. 13 and SEQ NO. 14 respectively, and the target sequence corresponding to them is SEQ NO.

15.

2. The set of primers according to claim 1 comprises one pair of common primers for four types of bifidobacteria and four pairs of specific primers for each of the four types of bifidobacteria, a total of five pairs of primers for the separation and identification of the four types of bifidobacteria.

3. The four bifidobacteria mentioned in claim 2 are Bifidobacterium breve ( B. breve ), Bifidobacterium longum subsp. longum ( B. longum subsp. longum )、Bifidobacterium bifidum( B. bifidum ) and Bifidobacterium longum subsp. infantis ( B. longum subsp. infantile ). That is, the primers designed in claim 1 are used for the separation and identification of these four bifidobacteria.

4. The use of a set of primers designed based on glycoside hydrolase (GH) family genes according to claim 3 for separating four types of bifidobacteria from complex samples, characterized in that: And should include the following steps: (1) Dilute and spread the sample to be tested, purify it and select a single colony (2) Optionally, enrich the single colony and extract DNA (3) The single colony obtained in step (1) or the DNA obtained in optional step (2) is subjected to PCR amplification using the primers shown above to obtain a PCR amplification product. (4) subjecting the amplified product to gel electrophoresis, and separating four types of bifidobacteria, namely, Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium longum subsp. longum, and Bifidobacterium longum subsp. infantis, according to the bands appearing in the gel electrophoresis; the electrophoresis result is one of the following: a: There are only DNA bands with molecular weights of 1055 bp and 641 bp, which are determined to be Bifidobacterium longum subsp. longum; b: There are only DNA bands with molecular weights of 1055 bp and 521 bp, which is determined to be Bifidobacterium breve; c: There are only DNA bands with molecular weights of 1055 bp and 843 bp, which is determined to be Bifidobacterium bifidum; d: There are only DNA bands with molecular weights of 1055 bp and 739 bp, which are determined to be Bifidobacterium longum subsp. infantis; e: No band or only one band means no result or a false positive result, which means it is not one of the four types of Bifidobacterium mentioned above.